Literature DB >> 2997400

Differential effects of alpha-adrenoceptor blockade on essential, physiological and isoprenaline-induced tremor: evidence for a central origin of essential tremor.

B Abila, J F Wilson, R W Marshall, A Richens.   

Abstract

Intravenous thymoxamine reduced the power of essential tremor but increased that of physiological and isoprenaline-induced tremor. These findings indicate that essential and physiological tremor have dissimilar pathophysiological mechanisms. They also suggest that central adrenergic mechanisms are involved in the pathophysiology of essential tremor and that isoprenaline-induced tremor is not a good model of essential tremor. Furthermore, alpha-adrenoceptor blockers may be a useful therapy for essential tremor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997400      PMCID: PMC1028544          DOI: 10.1136/jnnp.48.10.1031

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  The effect of alcohol on essential tremor.

Authors:  J H Growdon; B T Shahani; R R Young
Journal:  Neurology       Date:  1975-03       Impact factor: 9.910

2.  Finger tremor in tabetic patients and its bearing on the mechanism producing the rhythm of physiological tremor.

Authors:  A M HALLIDAY; J W REDFEARN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-05       Impact factor: 10.154

3.  Comparison of pre-junctional alpha-adrenoceptors at the neuromuscular junction with vascular post-junctional alpha-receptors in cat skeletal muscle.

Authors:  E Malta; G A McPherson; C Raper
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

4.  Thymoxamine and airways obstruction.

Authors:  J P Griffin; P L Kamburoff; F J Prime; A G Arbab
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

5.  The role of the ballistocardiac impulse in the genesis of physiological tremor.

Authors:  C D Marsden; J C Meadows; G W Lange; R S Watson
Journal:  Brain       Date:  1969       Impact factor: 13.501

6.  Depression of essential tremor by alpha-adrenergic blockade.

Authors:  J Mai; R B Olsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

7.  Participation of the stretch reflex in human physiological tremor.

Authors:  K E Hagbarth; R R Young
Journal:  Brain       Date:  1979-09       Impact factor: 13.501

8.  Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.

Authors:  E Perucca; H Pickles; A Richens
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

9.  Adrenergic control of tendon jerk reflexes in man.

Authors:  S J Phillips; A Richens; D G Shand
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

10.  The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration.

Authors:  S Calzetti; L J Findley; E Perucca; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

View more
  4 in total

1.  The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.

Authors:  T C Tham; J P McKaigue; S Guy; R G Shanks; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

2.  Characteristics of tail-tremor induced by nicotine in rats.

Authors:  K Suemaru; R Oishi; Y Gomita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

3.  Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia.

Authors:  Giulia Paparella; Gina Ferrazzano; Antonio Cannavacciuolo; Francesco Cogliati Dezza; Giovanni Fabbrini; Matteo Bologna; Alfredo Berardelli
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

4.  Beta-adrenergic modulation of tremor and corticomuscular coherence in humans.

Authors:  Mark R Baker; Stuart N Baker
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.